Clinical Trial Update: Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial comparing NI-071 with Remicade in patients with rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• NI-071
• Remicade (infliximab)

Snippet

Sponsor: Nichi-Iko Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED